Research Options:
Week of Expected Pricing Pending
Company Name CONKWEST, INC.
Proposed Ticker N/A
CUSIP 207371105
Business Description A pioneering clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases.
Lead Underwriter BofA Merrill Lynch, Citigroup Global Markets Inc, Jefferies LLC, Piper Jaffray & Co.
Co-Managers MLV & Co. LLC
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.